GSK's pediatric vaccines Synflorix wins international award at 2010 World Vaccine Congress

Published: 2010-06-03 06:56:00

Updated: 2010-06-03 06:56:00

Synflorix, GlaxoSmithKline’s childhood pneumococcal vaccine, has received outstanding recognition by winning the Best Prophylactic Vaccine at the recent Vaccine Industry Excellence awards held at the 2010 World Vaccine Congress in Washington.

The innovative vaccine was chosen for this award o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK